Cargando…

Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity

The perfusion of human tumour xenografts was manipulated by administration of diltiazem and pentoxifylline, and the extent that observed changes in tumour perfusion altered tumour radiosensitivity was determined. 2 tumour systems having intrinsically different types of hypoxia were studied. The resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Bennewith, K L, Durand, R E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363939/
https://www.ncbi.nlm.nih.gov/pubmed/11720448
http://dx.doi.org/10.1054/bjoc.2001.2123
_version_ 1782153829658132480
author Bennewith, K L
Durand, R E
author_facet Bennewith, K L
Durand, R E
author_sort Bennewith, K L
collection PubMed
description The perfusion of human tumour xenografts was manipulated by administration of diltiazem and pentoxifylline, and the extent that observed changes in tumour perfusion altered tumour radiosensitivity was determined. 2 tumour systems having intrinsically different types of hypoxia were studied. The responses of SiHa tumours, which have essentially no transient hypoxia, were compared to the responses of WiDr tumours, which contain chronically and transiently hypoxic cells. We found that relatively modest increases in net tumour perfusion increased tumour cell radiosensitivity in WiDr tumours to a greater extent than in SiHa tumours. Moreover, redistribution of blood flow within WiDr tumours was observed on a micro-regional level that was largely independent of changes in net tumour perfusion. Through fluorescence-activated cell sorting coupled with an in vivo–in vitro cloning assay, increases in the radiosensitivity of WiDr tumour cells at intermediate levels of oxygenation were observed, consistent with the expectation that a redistribution of tumour blood flow had increased oxygen delivery to transiently hypoxic tumour cells. Our data therefore suggest that drug-induced changes in tumour micro-perfusion can alter the radiosensitivity of transiently hypoxic tumour cells, and that increasing the radiosensitivity of tumour cells at intermediate levels of oxygenation is therapeutically relevant. © 2001 Cancer Research Campaign   http://www.bjcancer.com
format Text
id pubmed-2363939
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23639392009-09-10 Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity Bennewith, K L Durand, R E Br J Cancer Regular Article The perfusion of human tumour xenografts was manipulated by administration of diltiazem and pentoxifylline, and the extent that observed changes in tumour perfusion altered tumour radiosensitivity was determined. 2 tumour systems having intrinsically different types of hypoxia were studied. The responses of SiHa tumours, which have essentially no transient hypoxia, were compared to the responses of WiDr tumours, which contain chronically and transiently hypoxic cells. We found that relatively modest increases in net tumour perfusion increased tumour cell radiosensitivity in WiDr tumours to a greater extent than in SiHa tumours. Moreover, redistribution of blood flow within WiDr tumours was observed on a micro-regional level that was largely independent of changes in net tumour perfusion. Through fluorescence-activated cell sorting coupled with an in vivo–in vitro cloning assay, increases in the radiosensitivity of WiDr tumour cells at intermediate levels of oxygenation were observed, consistent with the expectation that a redistribution of tumour blood flow had increased oxygen delivery to transiently hypoxic tumour cells. Our data therefore suggest that drug-induced changes in tumour micro-perfusion can alter the radiosensitivity of transiently hypoxic tumour cells, and that increasing the radiosensitivity of tumour cells at intermediate levels of oxygenation is therapeutically relevant. © 2001 Cancer Research Campaign   http://www.bjcancer.com Nature Publishing Group 2001-11 /pmc/articles/PMC2363939/ /pubmed/11720448 http://dx.doi.org/10.1054/bjoc.2001.2123 Text en Copyright © 2001 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Regular Article
Bennewith, K L
Durand, R E
Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity
title Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity
title_full Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity
title_fullStr Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity
title_full_unstemmed Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity
title_short Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity
title_sort drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363939/
https://www.ncbi.nlm.nih.gov/pubmed/11720448
http://dx.doi.org/10.1054/bjoc.2001.2123
work_keys_str_mv AT bennewithkl druginducedalterationsintumourperfusionyieldincreasesintumourcellradiosensitivity
AT durandre druginducedalterationsintumourperfusionyieldincreasesintumourcellradiosensitivity